Hypercoagulability & Vascular Access Device Selection: Tailoring Device Choice to Disease State [virtual bundle]

Patients with hypercoagulable conditions present unique challenges for vascular access clinicians. Choosing the most appropriate vascular access device (VAD) requires balancing infusion therapy needs, vessel health preservation, and minimizing thrombosis risk. This session will explore hypercoagulable disease states, such as cancer-associated thrombosis, antiphospholipid antibody syndrome, and inherited thrombophilias, and discuss how each impacts device selection, dwell time, and maintenance practices. Attendees will review current evidence, clinical guidelines, and case scenarios that highlight the intersection of pathophysiology, device choice, and patient outcomes.

Learning Objectives: At the conclusion of this session, learners will be able to:  

• Identify common hypercoagulable disease states encountered in infusion and vascular access practice 

• Analyze how hypercoagulability influences the risk profile for peripherally inserted central catheters (PICCs), midline catheters, ports, and tunneled catheters 

• Apply evidence-based strategies to guide VAD selection and management for patients with elevated thrombotic risk 

• Integrate risk-mitigation approaches into patient education, insertion practices, and ongoing device maintenance 

Contact Hours: 1
CRNI® RUs: 2